Company · CIK 1405197
Talecris Biotherapeutics Holdings Corp.
| CIK | 1405197 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NC |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2009-11-09 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-144941 | 2007-07-27 | 2009-10-01 | 14 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2010-06-14 | EFFECTDeclared effective | 333-166052 | 9999999995-10-001798 |
| 2009-10-01 | 424B1Final prospectus | 333-144941 | 0001047469-09-008683 |
| 2009-09-30 | EFFECTDeclared effective | 333-144941 | 9999999995-09-002709 |
| 2009-09-28 | S-1/AAmendment | 333-144941 | 0001047469-09-008564 |
| 2009-09-21 | S-1/AAmendment | 333-144941 | 0001047469-09-008433 |
| 2009-09-11 | S-1/AAmendment | 333-144941 | 0001047469-09-008277 |
| 2009-08-19 | S-1/AAmendment | 333-144941 | 0001047469-09-007886 |
| 2009-07-21 | S-1/AAmendment | 333-144941 | 0001047469-09-006833 |
| 2009-07-02 | S-1/AAmendment | 333-144941 | 0001047469-09-006624 |
| 2008-07-23 | S-1/AAmendment | 333-144941 | 0001047469-08-008336 |
| 2007-12-19 | S-1/AAmendment | 333-144941 | 0001047469-07-010180 |
| 2007-11-13 | S-1/AAmendment | 333-144941 | 0001047469-07-009131 |
| 2007-10-19 | S-1/AAmendment | 333-144941 | 0001047469-07-007780 |
| 2007-09-24 | S-1/AAmendment | 333-144941 | 0001047469-07-007171 |
| 2007-07-27 | S-1Registration filed | 333-144941 | 0001047469-07-005901 |